EUVIMEDEUVIMED entdecken
Crossref

Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ

Xu Chen, Xiaohua Wei, Wanwan Yuan, Zhengzheng Liao, Chuanhua Feng, Shaofeng Xiong, Kun Wang, Guoqiang Yan, Ying Kong

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, People's Republic of C…. Hauptthemen laut MEDLINE: Hyperglycemia, Hyperlipidemias, Hydrolyzable Tannins, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Health and Family Planning Commission of Jiangxi Province, Jiangxi Provincial Natural Science Foundation, Nanchang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial dysfunction, a form of chronic endothelial inflammation, frequently occurs in patients with diabetes, hyperlipidemia, and hyperglycemia, which is a key trigger of cardiovascular diseases. Emerging evidence has indicated that pyroptosis plays a crucial role in endothelial dysfunction and potentially represents a promising therapeutic strategy. Punicalin (PUN), a bioactive compound derived from ellagitannins, has demonstrated great potential of anti-inflammatory and anti-pyroptosis. However, the specific protective mechanisms of PUN in vascular endothelial cells remain insufficiently explored. In this study, we developed endothelial dysfunction models to examine the effects of PUN on pyroptosis and endothelial function. Our findings reveal that PUN increases nitric oxide (NO) production, down regulates endothelin-1 (ET-1) levels, and activates the PI3K/Akt/eNOS pathway, thus enhancing endothelial function as evidenced by improving endothelium-dependent vasodilation. Additionally, PUN suppresses the generation of endogenous reactive oxygen species and inhibited the increasing levels of NLRP3, c-caspase-1, GSDMD-N, IL-1β, and IL-18 induced by high fat and high glucose condition, thereby reducing endothelial pyroptosis in both experimental settings. It also promotes phosphorylation of FOXO1 and reduces its accumulation in the nuclear, downregulating the NLRP3-Caspase-1 pathway and preventing FOXO1 from interacting with GSDMD, thereby preventing pyroptosis and ameliorating endothelial dysfunction. In conclusion, our results suggest that PUN alleviates endothelial dysfunction by enhancing the PI3K/Akt/eNOS pathway and suppressing NLRP3-caspase-1-mediated pyroptotic signaling. These findings indicate a potential therapeutic approach for preventing vascular complications in patients with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaHyperlipidemiasHydrolyzable TanninsEndothelial CellsPPAR gammaAnti-Inflammatory AgentsPyroptosisAnimalsMiceHumansMaleNitric OxideMice, Inbred C57BLSignal TransductionReactive Oxygen SpeciesNLR Family, Pyrin Domain-Containing 3 ProteinProto-Oncogene Proteins c-aktNitric Oxide Synthase Type IIIPhosphatidylinositol 3-KinasesCells, CulturedForkhead Box Protein O1

Stichwörter der Autor:innen

Endothelial cellHyperglycaemiaHyperlipidaemiaPPARγPunicalinPyroptosis

Substanzen

punicalaginHydrolyzable TanninsPPAR gammaNitric OxideAnti-Inflammatory AgentsReactive Oxygen SpeciesNLR Family, Pyrin Domain-Containing 3 ProteinProto-Oncogene Proteins c-aktNitric Oxide Synthase Type IIIPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, People's Republic of China; School of Pharmacy, Jiangxi Medical College, Nanchang University…
  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, People's Republic of China.
  • Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, People's Republic of China.
  • Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, People's Republic of China. Electronic address: ndyfy05893@ncu.edu.cn.

Förderung

  • Health and Family Planning Commission of Jiangxi Province
  • Jiangxi Provincial Natural Science Foundation
  • Nanchang University

Zitieren

APA

Chen, X., Wei, X., Yuan, W., Liao, Z., Feng, C., Xiong, S., Wang, K., Yan, G., & Kong, Y. (2025). Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115389

Vancouver

Chen X, Wei X, Yuan W, Liao Z, Feng C, Xiong S, et al. Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115389

BibTeX
@article{Chen2025,
  author = {Chen, Xu and Wei, Xiaohua and Yuan, Wanwan and Liao, Zhengzheng and Feng, Chuanhua and Xiong, Shaofeng and Wang, Kun and Yan, Guoqiang and Kong, Ying},
  title = {Punicalin ameliorates vascular endothelial cell pyroptosis and dysfunction induced by hyperlipidemia and hyperglycemia through activation of PPARγ},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115389}
}
Kostenlos starten →